A peptide certificate of analysis may contain a purity percentage, a chromatogram, a mass spectrum, or several other test results. These measurements are related, but they do not all answer the same question.
Understanding the difference between purity, identity, and quantity is essential when evaluating analytical documentation.
What does HPLC measure?
High-performance liquid chromatography, or HPLC, separates components in a sample according to how they interact with a stationary phase and a moving liquid phase.
Reversed-phase HPLC is widely used for peptide separation. Under a defined method, sample components travel through a chromatographic column at different rates, and a detector records the resulting signals as peaks on a chromatogram.[1]
A reported HPLC purity value is commonly calculated from the relative areas of detected peaks. For example, the area attributed to the principal peak may be compared with the total integrated peak area.
That number is meaningful only in the context of the method used. Results can be influenced by:
- Column chemistry
- Mobile-phase composition
- Gradient conditions
- Detection wavelength
- Sample concentration
- Integration settings
- The ability of the method to separate closely related components
Two laboratories can therefore obtain somewhat different results when they use different methods or acceptance criteria.
What HPLC does not establish by itself
A large chromatographic peak does not automatically prove that the peak contains the intended peptide. It shows that a major detected component eluted at a particular time under that method. An identity test is still needed.
HPLC purity also should not automatically be interpreted as the percentage of the entire vial mass consisting of peptide. A prepared material may contain water, counterions, residual salts, buffer components, or other substances that are not represented in the same way by a chromatographic peak-area calculation. That distinction is covered in detail in our article on HPLC purity versus peptide content.
Consequently, statements such as "99% HPLC purity" and "99% peptide by total mass" are not necessarily interchangeable.
What does mass spectrometry measure?
Mass spectrometry measures ions according to their mass-to-charge ratio. For a synthetic peptide with a known target sequence, mass spectrometry can determine whether the detected molecular mass is consistent with the proposed molecule.
Common approaches include matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and liquid chromatography-mass spectrometry. These methods are well suited to confirming the identity of synthetic peptides and investigating peptide-related components.[2]
More advanced LC-MS workflows can also help characterize impurities, sequence variants, oxidation products, truncations, and other structurally related compounds. In one study of synthetic human C-peptide material, high-resolution LC-MS methods detected and characterized more than 65 related impurities, illustrating how complex an impurity profile can become.[3]
HPLC and mass spectrometry answer different questions
A helpful simplified distinction is:
- Chromatography asks: how many detectable components can the method separate, and what proportion of the detected signal is associated with each peak?
- Mass spectrometry asks: what molecular masses or mass-to-charge signals are present, and are they consistent with the proposed molecule or related structures?
Using both techniques provides more information than either technique alone. Regulatory-quality characterization of peptide drug products can require additional orthogonal methods, impurity investigations, aggregation studies, biological testing, and method validation.[4] A basic research-material certificate should not be confused with the extensive data package required for an approved pharmaceutical product.
Reading a peptide certificate of analysis
When reviewing a certificate, consider the following questions. Our companion piece on how to read a peptide COA works through the same document field by field.
Is the certificate lot-specific?
The lot number on the certificate should correspond to the material being evaluated. A generic example certificate does not establish the results for every production lot.
Is the testing date shown?
A dated test result provides important context, particularly when material may change during storage.
Is the analytical method identified?
"HPLC tested" is less informative than a result that specifies the type of chromatography, detector, column, gradient, and acceptance criteria.
Is identity reported separately from purity?
Identity and chromatographic purity are different attributes. Ideally, the documentation clearly indicates which technique was used for each determination.
Are the underlying data included?
Chromatograms and spectra provide more context than a percentage or pass/fail statement alone. They may show peak shape, retention behavior, integration, ion signals, and other details relevant to interpretation.
Who performed the testing?
The certificate should identify the testing organization or explain whether the analysis was conducted internally or by an independent laboratory.
Are the methods validated?
A method can produce a result without necessarily being validated for specificity, accuracy, precision, linearity, range, and other performance characteristics. The level of validation needed depends on the research or regulatory application.
Why orthogonal testing matters
An orthogonal method evaluates a sample using a different scientific principle. For example, chromatography and mass spectrometry provide complementary information because one primarily separates components while the other evaluates ion mass.
FDA guidance concerning synthetic peptide drug products emphasizes orthogonal techniques and detailed impurity characterization.[5] This does not mean every research assay requires a pharmaceutical development program. It demonstrates, however, why a single purity number cannot completely describe a complex peptide material.
Key takeaway
HPLC purity, mass-spectrometric identity, peptide content, sterility, endotoxin status, and biological activity are separate analytical attributes.
A certificate of analysis is most useful when it identifies the exact lot, explains the methods, presents the relevant data, and avoids implying that one measurement proves every quality characteristic.
References
- Mant CT, Chen Y, Yan Z, et al. HPLC analysis and purification of peptides. Methods Mol Biol 2007;386:3-55. PMC7119934.
- Prabhala BK, Mirza O, Hojrup P, Hansen PR. Characterization of synthetic peptides by mass spectrometry. Methods Mol Biol 2015;1348:77-82. PMID: 26424265.
- Li M, Josephs RD, Daireaux A, et al. Identification and accurate quantification of structurally related peptide impurities in synthetic human C-peptide by LC-high resolution MS. Anal Bioanal Chem 2018;410:5059-5070. PMID: 29862433.
- ICH Q6A: Specifications - Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products (FDA, 2000) - Treats identification, assay, and impurities as distinct universal tests.
- FDA: ANDAs for Certain Highly Purified Synthetic Peptide Drug Products That Refer to Listed Drugs of rDNA Origin (Guidance for Industry, CDER, 2021).
Related educational articles
- How to Read a Peptide Certificate of Analysis (COA)
- HPLC Purity vs. Peptide Content: Why the Percentages Can Be Different
- Certificate of Analysis vs. Safety Data Sheet: What Is the Difference?
This article summarizes publicly available research for educational purposes and does not constitute medical advice, a therapeutic claim, or a recommendation for human use. Products referenced are sold for laboratory research use only.